. 2017 Apr 26;8(28):45898–45917. doi: 10.18632/oncotarget.17438

Table 1B. KRAS exon 2 population (N=36).

	KRAS wt		KRAS mut		KRAS wt		KRAS mut
	pp70S6K1^T389 ≤ median	pp70S6K1^T389 > median	pp70S6K1^T389 ≤ median	pp70S6K1^T389 > median	pAKT^S473 low	pAKT^S473 high	pAKT^S473 low	pAKT^S473 high
pERK1/2^T202/Y204≤ median	7	3	9	0	8	2	5	4
pERK1/2^T202/Y204> median	2	10	1	4	4	8	0	5
	p = 0.011, chi-square;odds ratio (95% CI): 11.667 (1.527-89.121)		p = 0.001, chi-square;odds ratio (95% CI): 5.000 (0.866-28.861)¹		p = 0.029, chi-square; odds ratio (95% CI): 8.000 (1.127-56.793)		p = 0.038, chi-square;odds ratio (95% CI): 0.444 (0.214-0.923)²

¹For pp70S6K1^T389 ≤ median cohort; ²for pAKT^S473 high cohort.